Medtronic plc (MDT) Return on equity 2017–2026
Medtronic plc (MDT) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
9.7%FY2026 · since FY2017: 8.0% → 9.7%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | 9.7% | -0.0 pp |
| FY2025 | 9.7% | +2.4 pp |
| FY2024 | 7.3% | +0.0 pp |
| FY2023 | 7.3% | -2.3 pp |
| FY2022 | 9.6% | +2.6 pp |
| FY2021 | 7.0% | -2.4 pp |
| FY2020 | 9.4% | +0.2 pp |
| FY2019 | 9.2% | +3.1 pp |
| FY2018 | 6.1% | -1.9 pp |
| FY2017 | 8.0% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice